Endoscopic submucosal dissection (ESD) is widely used for local treatment of gastric
neoplasms. Although ESD-related complications such as bleeding and perforation have been
reported, data is currently lacking on the development of pain, which is one of the most
common adverse events after ESD. Therefore, in the present study, we investigated the
incidence and clinicopathologic risk factors of pain after ESD.